<b>CIRC</b> Shares Surge Over 5% After Joint Venture Formation with CNNC Zhechuang

Stock News08-03

CIRC (01763) shares climbed more than 5%, trading at HKD 17.13 as of the time of writing, with a turnover of HKD 1.494 million.

The company recently announced that it has entered into a shareholder agreement with CNNC Zhechuang to establish a joint venture named CNNC Fuzhi. The registered capital of the joint venture is RMB 50 million, with CIRC contributing RMB 45 million in a combination of non-monetary assets and cash, including RMB 26.6 million in cash and RMB 18.4 million in net assets from its Nuclear Medicine Development Center. CNNC Zhechuang will contribute RMB 5 million in cash.

Upon formation, CIRC and CNNC Zhechuang will hold 90% and 10% stakes in the joint venture, respectively, making it a non-wholly owned subsidiary of CIRC. The joint venture will take over the business of the Nuclear Medicine Development Center, focusing on the smart nuclear medicine industry. It aims to integrate the entire "nuclear medicine" value chain, foster a collaborative model of "smart nuclear medicine, radiopharmaceuticals, and equipment," and transition from a single-product supply to a full-value chain integrated service. This initiative is expected to drive standardization and smart transformation in the nuclear medicine sector, strengthen the company's leadership position, and cultivate new profit growth drivers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115671538?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 13:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115671538","market":"sg","top_or_hot":-1,"title":"<b>CIRC</b> Shares Surge Over 5% After Joint Venture Formation with CNNC Zhechuang","media":"Stock News","content":"<p><b>CIRC</b> (01763) shares climbed more than 5%, trading at HKD 17.13 as of the time of writing, with a turnover of HKD 1.494 million.<br><br>The company recently announced that it has entered into a shareholder agreement with <b>CNNC Zhechuang</b> to establish a joint venture named <b>CNNC Fuzhi</b>. The registered capital of the joint venture is RMB 50 million, with <b>CIRC</b> contributing RMB 45 million in a combination of non-monetary assets and cash, including RMB 26.6 million in cash and RMB 18.4 million in net assets from its Nuclear Medicine Development Center. <b>CNNC Zhechuang</b> will contribute RMB 5 million in cash.<br><br>Upon formation, <b>CIRC</b> and <b>CNNC Zhechuang</b> will hold 90% and 10% stakes in the joint venture, respectively, making it a non-wholly owned subsidiary of <b>CIRC</b>. The joint venture will take over the business of the Nuclear Medicine Development Center, focusing on the smart nuclear medicine industry. It aims to integrate the entire \"nuclear medicine\" value chain, foster a collaborative model of \"smart nuclear medicine, radiopharmaceuticals, and equipment,\" and transition from a single-product supply to a full-value chain integrated service. This initiative is expected to drive standardization and smart transformation in the nuclear medicine sector, strengthen the company's leadership position, and cultivate new profit growth drivers.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title><b>CIRC</b> Shares Surge Over 5% After Joint Venture Formation with CNNC Zhechuang</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n<b>CIRC</b> Shares Surge Over 5% After Joint Venture Formation with CNNC Zhechuang\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-03 13:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>CIRC</b> (01763) shares climbed more than 5%, trading at HKD 17.13 as of the time of writing, with a turnover of HKD 1.494 million.<br><br>The company recently announced that it has entered into a shareholder agreement with <b>CNNC Zhechuang</b> to establish a joint venture named <b>CNNC Fuzhi</b>. The registered capital of the joint venture is RMB 50 million, with <b>CIRC</b> contributing RMB 45 million in a combination of non-monetary assets and cash, including RMB 26.6 million in cash and RMB 18.4 million in net assets from its Nuclear Medicine Development Center. <b>CNNC Zhechuang</b> will contribute RMB 5 million in cash.<br><br>Upon formation, <b>CIRC</b> and <b>CNNC Zhechuang</b> will hold 90% and 10% stakes in the joint venture, respectively, making it a non-wholly owned subsidiary of <b>CIRC</b>. The joint venture will take over the business of the Nuclear Medicine Development Center, focusing on the smart nuclear medicine industry. It aims to integrate the entire \"nuclear medicine\" value chain, foster a collaborative model of \"smart nuclear medicine, radiopharmaceuticals, and equipment,\" and transition from a single-product supply to a full-value chain integrated service. This initiative is expected to drive standardization and smart transformation in the nuclear medicine sector, strengthen the company's leadership position, and cultivate new profit growth drivers.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159891","symbol_name":"医疗","start_time":0,"source_url":"","article_id":"1115671538","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115671538","pubTimestamp":1785736218,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CIRC (01763) shares climbed more than 5%, trading at HKD 17.13 as of the time of writing, with a turnover of HKD 1.494 million.The company recently announced that it has entered into a shareholder...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","KCAI":"KraneShares China Alpha Index ETF","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK1222":"医疗保健用品","01763":"中国同辐","VXUS":"国际股票ETF-Vanguard"},"translate_title":"<b>保监会</b>与中核浙创成立合资公司后股价飙升逾5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"KCAI":1,"VXUS":1,"01763":1},"content_text":"CIRC (01763) shares climbed more than 5%, trading at HKD 17.13 as of the time of writing, with a turnover of HKD 1.494 million.The company recently announced that it has entered into a shareholder agreement with CNNC Zhechuang to establish a joint venture named CNNC Fuzhi. The registered capital of the joint venture is RMB 50 million, with CIRC contributing RMB 45 million in a combination of non-monetary assets and cash, including RMB 26.6 million in cash and RMB 18.4 million in net assets from its Nuclear Medicine Development Center. CNNC Zhechuang will contribute RMB 5 million in cash.Upon formation, CIRC and CNNC Zhechuang will hold 90% and 10% stakes in the joint venture, respectively, making it a non-wholly owned subsidiary of CIRC. The joint venture will take over the business of the Nuclear Medicine Development Center, focusing on the smart nuclear medicine industry. It aims to integrate the entire \"nuclear medicine\" value chain, foster a collaborative model of \"smart nuclear medicine, radiopharmaceuticals, and equipment,\" and transition from a single-product supply to a full-value chain integrated service. This initiative is expected to drive standardization and smart transformation in the nuclear medicine sector, strengthen the company's leadership position, and cultivate new profit growth drivers.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115671538","isCrawlerRequest":true}